These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 4140845)
21. Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives. Hofheinz RD; Beyer U; Al-Batran SE; Hartmann JT Onkologie; 2008 May; 31(5):271-81. PubMed ID: 18497518 [TBL] [Abstract][Full Text] [Related]
22. [Mytomycin C nephrotoxicity. 3 new cases and review of the literature]. Simon P; Hervé JP; Ramée MP; Leroy JP; Ang KS; Leguy P; Vignoud J; Cledes J Nephrologie; 1982; 3(4):152-7. PubMed ID: 6818483 [TBL] [Abstract][Full Text] [Related]
23. Mitomycin C: experience in the United States, with emphasis on gastric cancer. Schein PS; MacDonald JS; Hoth D; Woolley PV Recent Results Cancer Res; 1978; 63():148-51. PubMed ID: 705009 [No Abstract] [Full Text] [Related]
24. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur]. Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998 [TBL] [Abstract][Full Text] [Related]
26. Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer. Dieras V; Marty M; Tubiana N; Corette L; Morvan F; Serin D; Mignot L; Chazard M; Garet F; Onetto N Semin Oncol; 1995 Aug; 22(4 Suppl 8):33-9. PubMed ID: 7638640 [TBL] [Abstract][Full Text] [Related]
27. An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. A pilot study of the Southeastern Cancer Study Group. Lawson D; Moore M; Smalley R Cancer Clin Trials; 1980; 3(4):293-6. PubMed ID: 6775826 [TBL] [Abstract][Full Text] [Related]
29. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports]. Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335 [TBL] [Abstract][Full Text] [Related]
30. [Neuroendocrine tumours of the gastrointestinal tract]. Plöckinger U; Wiedenmann B Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448 [TBL] [Abstract][Full Text] [Related]
31. Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study. Leichman LP; Baker LH; Stanhope CR; Samson MK; Fraile RJ; Vaitkevicius VK; Hilgers R Cancer Treat Rep; 1980; 64(10-11):1139-40. PubMed ID: 6161699 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic use of mitomycin C in bladder cancer. Denis L Prog Clin Biol Res; 1984; 162B():113-22. PubMed ID: 6438638 [No Abstract] [Full Text] [Related]
33. Comparative study of methods of administering mitomycin C. Matsunaga F; Shimoyama T; Mikawa K; Ishiwata J Cancer; 1967 May; 20(5):805-8. PubMed ID: 4290387 [No Abstract] [Full Text] [Related]
34. A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study. van Oosterom AT; Powles TJ; Hamersma E; Smith IE; Engelsman E Eur J Cancer (1965); 1980; Suppl 1():275-6. PubMed ID: 6797825 [No Abstract] [Full Text] [Related]
35. Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study. Gagliano RG; Panettiere FJ; Haas CD; Baker L; Hewlett J; Stuckey WJ; O'Bryan RM; Bottomley R; Heilburn LK Cancer Clin Trials; 1981; 4(4):401-5. PubMed ID: 7318121 [TBL] [Abstract][Full Text] [Related]